In a letter to CVS obtained by the news outlet, Rep. Jim Jordan, chair of the House Judiciary Committee, requested documents and communications related to pharmaceutical hubs.
In the letter, Mr. Jordan raised concerns that CVS may be preventing independent pharmacies from participating in these hubs, potentially stifling competition. If an independent pharmacy collaborates with a hub outside of CVS’ network, it could be excluded from the PBM’s access.
Pharmaceutical hubs, often sponsored by drugmakers, facilitate the connection between manufacturers and specialty pharmacies to help patients access and manage high-cost medications.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
